Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CADENCE PHARMACEUTICALS INC Financial Overview

  • Income Statement: CADX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 0.00 0.00 N/A%
    Gross Profit -529,646.00 -515,763.00 -13,883.00 2.62%
    Net Income Before Extra Items/Preferred Div -57.10 M -51.71 M -5.39 M 9.43%
    Operating Income -54.15 M -54.23 M 85,654.00 -0.16%
  • Cash Flow: CADX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 43.53 M 12.62 M 30.91 M 71.00%
    Net Cash Flow - Investing 1.61 M 3.38 M -1.77 M -110.30%
    Net Cash Flow/Operating Activities -49.69 M -40.67 M -9.01 M 18.14%
  • Balance Sheet: CADX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 55.15 M 64.61 M -9.46 M -17.16%
    Total Liabilities 28.71 M 36.15 M -7.45 M -25.94%
    Shareholders Equity 26.44 M 28.46 M -2.02 M -7.63%
  • Key Ratios / Statistics: CADX

    • Valuation

      Price/Earnings (TTM) -4.66
      Price/Sales (TTM)
      Price/Book (MRQ) 5.18
      Price/Cash Flow (TTM) -11.33
    • Profitability

      Gross Margin
      Operating Margin
      Profit Margin
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.30
      Current Ratio (MRQ) 7.91
      Long Term Debt-to-Equity (MRQ) 3.27
    • Management Effectiveness

      Return on Equity (TTM) -186.00
      Return on Assets (TTM) -44.82
      Return on Investments (TTM) -127.34